Tgflux Pharmaceuticals Private Limited
About Tgflux Pharmaceuticals Private Limited
Data last updated:
Tgflux Pharmaceuticals Private Limited was a private limited company based in Navi Mumbai, Maharashtra, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 May 2018.
The company was registered with the Registrar of Companies (ROC), Mumbai, under CIN U74999MH2018PTC308944.
The company had an authorised share capital of ₹1 Lakh. It was led by directors Amit Kumar Ghosh and Sandeep Khandu Tekle.
Its last annual general meeting (AGM) was held on 03 October 2020, and its latest financial statements are for the year ended 31 March 2020. The registered office was at R No. 301 Plot No. 21 Sector 4 Nerul, Navi Mumbai, Maharashtra, India – 400706.
Company details
Contact details
Tgflux Pharmaceuticals Private Limited's registered office is in Navi Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressR No. 301 Plot No. 21 Sector 4 Nerul, Navi Mumbai, Maharashtra, India – 400706
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Tgflux Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Tgflux Pharmaceuticals Private Limited
FY 2020 filings availableFinancial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ||
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ||
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | ||
| Net Profit Margin | ||
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Tgflux Pharmaceuticals Private Limited, buy the company report.
Board of directors of Tgflux Pharmaceuticals Private Limited
Tgflux Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amit Kumar Ghosh Also directs: Reflux Pharmaceuticals Private Limited | Director | 04 May 2018 | 8 Years 6 Months | As last reported |
| Sandeep Khandu Tekle | Director | 04 May 2018 | 8 Years 6 Months | As last reported |
Auditor
Tgflux Pharmaceuticals Private Limited is audited by VIDYADHAR & CO for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIDYADHAR & CO | FY 2020 | 131030W |
Shareholding
The shareholding of Tgflux Pharmaceuticals Private Limited is on record for FY 2020, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2020 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Tgflux Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Tgflux Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Tgflux Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Tgflux Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Tgflux Pharmaceuticals Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Amit Kumar Ghosh was appointed as Director on 04 May 2018.
Frequently asked questions
Tgflux Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Tgflux Pharmaceuticals was a private limited company based in Navi Mumbai, Maharashtra, India. The company worked in drug formulation and development, within the pharma industry. It was incorporated on 04 May 2018 and is registered under CIN U74999MH2018PTC308944. The company has been struck off by the Registrar of Companies and is no longer operational.
Tgflux Pharmaceuticals had 2 directors:
- Amit Kumar Ghosh - Director
- Sandeep Khandu Tekle - Director
The CIN (Corporate Identification Number) of Tgflux Pharmaceuticals is U74999MH2018PTC308944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Tgflux Pharmaceuticals is at R No. 301 Plot No. 21 Sector 4 Nerul, Navi Mumbai, Maharashtra, India – 400706.
Tgflux Pharmaceuticals was incorporated on 04 May 2018. It is registered with the Registrar of Companies, Mumbai.
The latest financial statements of Tgflux Pharmaceuticals on record with the MCA are for the year ended 31 March 2020. Its last annual general meeting was held on 03 October 2020. Year-wise statements from FY 2019 are in the company report.
Tgflux Pharmaceuticals operated in the pharma industry, in the drug formulation and development segment. It worked in this industry before it was struck off.
Amit Kumar Ghosh was appointed as Director on 04 May 2018. Sandeep Khandu Tekle was appointed as Director on 04 May 2018.
Tgflux Pharmaceuticals can be reached at its registered office: R No. 301 Plot No. 21 Sector 4 Nerul, Navi Mumbai, Maharashtra, India – 400706.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
